HealthWarehouse.com, Inc. (HEWA)
USD 0.08
(-11.11%)
USD 0.08
(-11.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.27 Million USD | -128.01% |
| 2022 | -559.33 Thousand USD | -148.86% |
| 2021 | -224.76 Thousand USD | -366.14% |
| 2020 | 84.45 Thousand USD | -73.56% |
| 2019 | 319.35 Thousand USD | 225.87% |
| 2018 | -253.7 Thousand USD | -147.93% |
| 2017 | 555.07 Thousand USD | 141.06% |
| 2016 | -1.13 Million USD | -273.04% |
| 2015 | -234.21 Thousand USD | 77.87% |
| 2014 | -1.27 Million USD | 31.39% |
| 2013 | -5.06 Million USD | 39.07% |
| 2012 | -4.12 Million USD | 17.25% |
| 2011 | -4.44 Million USD | -55.01% |
| 2010 | -2.86 Million USD | -17.75% |
| 2009 | -2.37 Million USD | -278.85% |
| 2008 | -656.68 Thousand USD | 76.85% |
| 2007 | -1.36 Million USD | -174.13% |
| 2006 | -947.28 Thousand USD | -949.74% |
| 2005 | -38.08 Thousand USD | 81.94% |
| 2004 | -362.02 Thousand USD | 40.4% |
| 2003 | -504.93 Thousand USD | 82.6% |
| 2002 | -5.23 Million USD | 8.9% |
| 2001 | -5.18 Million USD | -384.87% |
| 2000 | -9.5 Million USD | -162.32% |
| 1999 | -1.18 Million USD | 111.11% |
| 1998 | -1.6 Million USD | 80.0% |
| 1997 | 500 Thousand USD | 171.43% |
| 1996 | 600 Thousand USD | -187.5% |
| 1995 | -800 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -73.47 Thousand USD | 85.68% |
| 2024 Q2 | -163.18 Thousand USD | -122.12% |
| 2023 Q2 | -364.24 Thousand USD | -52.45% |
| 2023 FY | - USD | -128.01% |
| 2023 Q3 | -159.01 Thousand USD | 56.35% |
| 2023 Q1 | -238.92 Thousand USD | -357.01% |
| 2023 Q4 | -513.12 Thousand USD | -222.7% |
| 2022 Q1 | -138.84 Thousand USD | -467.51% |
| 2022 FY | - USD | -148.86% |
| 2022 Q3 | -150.45 Thousand USD | 30.91% |
| 2022 Q4 | -52.27 Thousand USD | 65.25% |
| 2022 Q2 | -217.76 Thousand USD | -56.84% |
| 2021 FY | - USD | -366.14% |
| 2021 Q4 | 37.78 Thousand USD | 136.63% |
| 2021 Q1 | -54.42 Thousand USD | -106.1% |
| 2021 Q2 | -104.97 Thousand USD | -92.9% |
| 2021 Q3 | -103.14 Thousand USD | 1.75% |
| 2020 Q4 | 891.58 Thousand USD | 1311.7% |
| 2020 Q1 | 21.03 Thousand USD | -73.04% |
| 2020 Q2 | -1327.00 USD | -106.31% |
| 2020 Q3 | 63.15 Thousand USD | 4859.38% |
| 2020 FY | - USD | -73.56% |
| 2019 Q2 | 43.75 Thousand USD | -55.49% |
| 2019 Q4 | 78.02 Thousand USD | -21.4% |
| 2019 FY | - USD | 225.87% |
| 2019 Q3 | 99.26 Thousand USD | 126.84% |
| 2019 Q1 | 98.3 Thousand USD | 43.66% |
| 2018 Q1 | -266.1 Thousand USD | -118.45% |
| 2018 FY | - USD | -147.93% |
| 2018 Q2 | -62.08 Thousand USD | 76.67% |
| 2018 Q3 | 6055.00 USD | 109.75% |
| 2018 Q4 | 68.43 Thousand USD | 1030.14% |
| 2017 Q3 | 104.26 Thousand USD | -74.74% |
| 2017 FY | - USD | 141.06% |
| 2017 Q4 | -121.81 Thousand USD | -216.84% |
| 2017 Q2 | 412.82 Thousand USD | 144.17% |
| 2017 Q1 | 169.06 Thousand USD | 341.85% |
| 2016 FY | - USD | -273.04% |
| 2016 Q2 | -11.5 Thousand USD | 93.68% |
| 2016 Q1 | -182.22 Thousand USD | -112.48% |
| 2016 Q3 | -902.82 Thousand USD | -7744.55% |
| 2016 Q4 | -69.9 Thousand USD | 92.26% |
| 2015 Q4 | -85.76 Thousand USD | -7.32% |
| 2015 Q3 | -79.91 Thousand USD | -775.12% |
| 2015 Q2 | 11.83 Thousand USD | 114.73% |
| 2015 Q1 | -80.37 Thousand USD | 89.04% |
| 2015 FY | - USD | 77.87% |
| 2014 Q2 | -237.15 Thousand USD | -24.5% |
| 2014 Q3 | -400.3 Thousand USD | -68.79% |
| 2014 FY | - USD | 31.39% |
| 2014 Q1 | -190.48 Thousand USD | -12770.54% |
| 2014 Q4 | -733.33 Thousand USD | -83.19% |
| 2013 FY | - USD | 39.07% |
| 2013 Q4 | -1480.00 USD | 99.84% |
| 2013 Q3 | -920.61 Thousand USD | -426.19% |
| 2013 Q2 | -174.95 Thousand USD | 85.15% |
| 2013 Q1 | -1.17 Million USD | -1230.0% |
| 2012 Q2 | -1.27 Million USD | -13.56% |
| 2012 Q3 | -1.24 Million USD | 2.21% |
| 2012 FY | - USD | 17.25% |
| 2012 Q4 | -88.6 Thousand USD | 92.9% |
| 2012 Q1 | -1.12 Million USD | 28.32% |
| 2011 FY | - USD | -55.01% |
| 2011 Q1 | -896.28 Thousand USD | 35.38% |
| 2011 Q3 | -1.1 Million USD | -16.65% |
| 2011 Q4 | -1.56 Million USD | -42.04% |
| 2011 Q2 | -946.08 Thousand USD | -5.56% |
| 2010 Q1 | -205.51 Thousand USD | 80.22% |
| 2010 FY | - USD | -17.75% |
| 2010 Q2 | -571.83 Thousand USD | -178.25% |
| 2010 Q3 | -747.67 Thousand USD | -30.75% |
| 2010 Q4 | -1.38 Million USD | -85.5% |
| 2009 Q2 | -369.5 Thousand USD | -42.49% |
| 2009 FY | - USD | -278.85% |
| 2009 Q4 | -1.03 Million USD | -79.18% |
| 2009 Q3 | -579.8 Thousand USD | -56.92% |
| 2009 Q1 | -259.3 Thousand USD | -193.92% |
| 2008 Q3 | -129.23 Thousand USD | 36.94% |
| 2008 Q2 | -204.92 Thousand USD | 11.04% |
| 2008 Q1 | -230.35 Thousand USD | 90.08% |
| 2008 Q4 | -88.22 Thousand USD | 31.73% |
| 2008 FY | - USD | 76.85% |
| 2007 Q1 | -117.17 Thousand USD | 59.47% |
| 2007 FY | - USD | -174.13% |
| 2007 Q4 | -2.32 Million USD | -1635.64% |
| 2007 Q3 | -133.78 Thousand USD | 45.83% |
| 2007 Q2 | -246.97 Thousand USD | -110.77% |
| 2006 Q3 | -221.6 Thousand USD | -117.11% |
| 2006 Q1 | -415.9 Thousand USD | -1257.28% |
| 2006 FY | - USD | -949.74% |
| 2006 Q4 | -289.1 Thousand USD | -30.46% |
| 2006 Q2 | -102.06 Thousand USD | 75.46% |
| 2005 Q1 | -75.75 Thousand USD | 19.65% |
| 2005 Q4 | 35.93 Thousand USD | -45.02% |
| 2005 Q3 | 65.36 Thousand USD | 170.93% |
| 2005 Q2 | -92.15 Thousand USD | -21.65% |
| 2005 FY | - USD | 81.94% |
| 2004 FY | - USD | 40.4% |
| 2004 Q1 | -224.99 Thousand USD | -842.4% |
| 2004 Q2 | -202.4 Thousand USD | 10.04% |
| 2004 Q3 | -20.87 Thousand USD | 89.69% |
| 2004 Q4 | -94.28 Thousand USD | -351.6% |
| 2003 Q4 | -27.99 Thousand USD | 78.93% |
| 2003 Q2 | -60.01 Thousand USD | 41.54% |
| 2003 Q1 | -642.97 Thousand USD | 0.0% |
| 2003 FY | - USD | 82.6% |
| 2003 Q3 | 103.2 Thousand USD | 69.85% |
| 2002 Q1 | -770.16 Thousand USD | 23.59% |
| 2002 Q3 | -929.71 Thousand USD | 56.16% |
| 2002 Q2 | -1.76 Million USD | -129.65% |
| 2002 FY | - USD | 8.9% |
| 2001 Q1 | -1.55 Million USD | -166.35% |
| 2001 Q3 | -1.84 Million USD | -18.58% |
| 2001 Q4 | -960.74 Thousand USD | 45.48% |
| 2001 FY | - USD | -384.87% |
| 2001 Q2 | -1.55 Million USD | -26.09% |
| 2000 Q3 | -3.21 Million USD | 11.34% |
| 2000 FY | - USD | -162.32% |
| 2000 Q1 | -1.58 Million USD | -892.01% |
| 2000 Q2 | -3.63 Million USD | -129.2% |
| 2000 Q4 | -1.09 Million USD | 157.89% |
| 1999 FY | - USD | 111.11% |
| 1999 Q2 | -100 Thousand USD | 96.43% |
| 1999 Q4 | 200 Thousand USD | -60.0% |
| 1999 Q3 | 500 Thousand USD | 600.0% |
| 1999 Q1 | -2.8 Million USD | -800.0% |
| 1998 Q2 | 500 Thousand USD | 0.0% |
| 1998 Q1 | 500 Thousand USD | 25.0% |
| 1998 FY | - USD | 80.0% |
| 1998 Q4 | 400 Thousand USD | 33.33% |
| 1998 Q3 | 300 Thousand USD | -40.0% |
| 1997 Q2 | -100 Thousand USD | -200.0% |
| 1997 FY | - USD | 171.43% |
| 1997 Q1 | 100 Thousand USD | -50.0% |
| 1997 Q4 | 400 Thousand USD | 100.0% |
| 1997 Q3 | 200 Thousand USD | 300.0% |
| 1996 Q2 | 300 Thousand USD | 200.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 FY | - USD | -187.5% |
| 1996 Q1 | -300 Thousand USD | -250.0% |
| 1996 Q3 | 200 Thousand USD | -33.33% |
| 1995 Q4 | 200 Thousand USD | 125.0% |
| 1995 Q3 | -800 Thousand USD | -500.0% |
| 1995 Q2 | 200 Thousand USD | 104.26% |
| 1995 FY | - USD | 0.0% |
| 1995 Q1 | -4.7 Million USD | -361.11% |
| 1994 Q3 | 1.8 Million USD | 0.0% |
| 1994 Q2 | 1.8 Million USD | 0.0% |
| 1994 Q4 | 1.8 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | -507767.867% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | -427.451% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 101.427% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 9.891% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | -2559.216% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 102.7% |
| MedGen, Inc. | -15.37 USD | -8297278.009% |
| Omni Health, Inc. | 1.28 Million USD | 199.045% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | -270.765% |
| Pineapple, Inc. | -1.47 Million USD | 13.555% |
| ScripsAmerica, Inc. | -3.95 Million USD | 67.75% |